For Congenital Deafness, a Chinese Trial Opens a Path to Sound

Trust My Science

Factuality

Ownership

The world's first gene therapy against congenital deafness was approved by the American Food and Drug Administration (FDA), following clinical trials with promising results. Developed by the biotech laboratory Regeneron, the therapy targets mutations of the OTOF gene, which codes for the protein allowing ciliated cells of the inner ear [...] This article A world first: the FDA approves a gene therapy against congenital deafness appeared first on…

duplos.cl

Factuality

Ownership

An innovative study reveals that gene therapy can restore hearing in children with congenital deafness, offering new hope for the treatment of this condition.

n1info.rs

Factuality

Ownership

A new gene therapy tested in China improved hearing in 38 people who were born deaf due to mutations in the OTOF gene.